Form 4: BioCryst Pharmaceuticals Chief Legal Officer Increases Stake with $5.53 per Share Purchase

Alane P. Barnes, Chief Legal Officer of BioCryst Pharmaceuticals, recently acquired 5,000 shares of common stock at an average price of $5.53 per share, increasing her total holdings to 300,762 shares.

Summary

• On May 13, 2024, Alane P. Barnes, the Chief Legal Officer of BioCryst Pharmaceuticals Inc. (BCRX), purchased 5,000 shares of the company's common stock.
• The shares were acquired at a weighted average price of $5.53.
• The purchases were made in multiple transactions with prices ranging from $5.36 to $5.64.
• Following the transaction, Barnes directly owns 300,762 shares of BioCryst Pharmaceuticals.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the Chief Legal Officer increasing their stake in the company suggests confidence in its future.

Positives

• The purchase of shares by a company officer can be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Purchases are generally viewed more favorably than sales.

Stakeholder Impact

• The increased stake of a key officer could boost investor confidence.

Key Dates